drugset / Trial / NCT02296346
Open-Label Study to Evaluate the Efficacy of ECP in Secondary Progressive Multiple Sclerosis
RandomizedSingle-groupOpen-labelTreatment
Summary
In this research study, the investigators will determine whether a procedure called Extracorporeal Photopheresis (ECP) is helpful in preventing progression of disability in people with SPMS when compared to monthly corticosteroid infusions. This study will determine whether ECP has an effect on inflammatory cells in people with SPMS and whether it has a beneficial therapeutic effect.
Timeline
- Start
- 2014-10
- Primary completion
- 2017-06-13
- Completion
- 2018-05-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylprednisolone | Other / unclassified | 1 g | Subcutaneous |